BIOMED CONSULTING AS
Operating
Konsulentvirksomhet innen biologisk og medisinske fagområder, samt å
foreta investeringer.
Konsulentvirksomhet innen biologisk og medisinsk virksomhet.
Organization
- CEO
- TS
- Chairman of the board
- TS
- Years since formation
- 28 years
- since Jul 6, 1998
- Type
- Limited company
- VAT registered
- Yes
- Number of employees
- 0
Ownership
- Number of shares and share classes
- 500
- 1 share class
- Total number of shareholders
- 4
- persons
Financials
- Total operating income 2025
- 206,372
- NOK
- Annual total result 2025
- 219,291
- NOK
- Total equity 2025
- 5,738,754
- NOK
Last update: Jul 2, 2026
Management
Management / administration
| Name | Role | Shares |
|---|---|---|
TS | Managing Director/CEO | 64 % directly |
Board
| Name | Role | Shares |
|---|---|---|
TS | Chairman | 64 % directly |
TE 1974 | Board Member | 12 % directly |
AR | Board Member | 12 % directly |
| Alternate Member | - |
Others
| Name | Role | Shares |
|---|---|---|
| Accountant | - |
Top 10 individual shareholders
| Name | Role | Shares |
|---|---|---|
TS | Managing Director/CEO, Chairman | 64 % directly |
TE 1974 | Board Member | 12 % directly |
AR | Board Member | 12 % directly |
CE | - | 12 % directly |
Last update: Apr 13, 2023
Ownership
Company shareholders
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
TS | Ordinary shares | 320 | 64 % |
AR | Ordinary shares | 60 | 12 % |
CE | Ordinary shares | 60 | 12 % |
TE 1974 | Ordinary shares | 60 | 12 % |
Shares owned by the BIOMED CONSULTING AS
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
| NO0010756042 | 26,075 | 0.08 % | |
| NO0003033102 | 1,700 | < 0.01 % |
Last update: Jun 2, 2025
Financials
in NOK
Summary
| Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
Total operating income | 206,372 | 954,687 | 1,189,437 | 1,347,994 | 1,129,388 |
Annual Total Result | 219,291 | 1,383,505 | 686,277 | 897,055 | 622,283 |
Total assets | 5,774,271 | 5,734,145 | 4,415,796 | 3,780,205 | 2,814,678 |
Total liabilities | 35,517 | 214,683 | 279,839 | 330,525 | 262,053 |
Total equity | 5,738,754 | 5,519,462 | 4,135,958 | 3,449,680 | 2,552,625 |
P&L
| Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
Total operating income | 206,372 | 954,687 | 1,189,437 | 1,347,994 | 1,129,388 |
Total operating costs | 182,876 | 214,127 | 124,426 | 160,138 | 80,777 |
Operating result | 23,496 | 740,560 | 1,065,011 | 1,187,856 | 1,048,611 |
Financial income/costs | 201,547 | 804,973 | -144,415 | -29,457 | -195,244 |
Profit before tax | 225,043 | 1,545,533 | 920,596 | 1,158,399 | 853,368 |
Total tax & extraordinary income/cost | 5,752 | 162,028 | 234,319 | 261,344 | 231,085 |
Annual Total Result | 219,291 | 1,383,505 | 686,277 | 897,055 | 622,283 |
Balance overview
| Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
Total fixed assets | 0 | 0 | 0 | 0 | 0 |
Total current assets | 5,774,271 | 5,734,145 | 4,415,796 | 3,780,205 | 2,814,678 |
Total assets | 5,774,271 | 5,734,145 | 4,415,796 | 3,780,205 | 2,814,678 |
Short term debt | 35,517 | 214,683 | 279,839 | 330,525 | 262,053 |
Long term debt | 0 | 0 | 0 | 0 | 0 |
Total liabilities | 35,517 | 214,683 | 279,839 | 330,525 | 262,053 |
Contributed capital | 100,000 | 100,000 | 100,000 | 100,000 | 100,000 |
Retained earnings | 5,638,754 | 5,419,462 | 4,035,958 | 3,349,680 | 2,452,625 |
Total equity | 5,738,754 | 5,519,462 | 4,135,958 | 3,449,680 | 2,552,625 |
Total equity and liabilities | 5,774,271 | 5,734,145 | 4,415,796 | 3,780,205 | 2,814,678 |
Classification
21st company classification
BETA
Small company
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises